Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dapagliflozin (10mg) + Gliclazide (60mg) Tablet
Therapeutic Category
Antidiabetic, Cardiology, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dapoflit G Tablet contains Dapagliflozin 10mg and Gliclazide 60mg, a dual-action anti-diabetic formulation designed to manage type 2 diabetes effectively. The combination helps achieve better glycemic control and reduces the risk of long-term complications.
The tablet works by enhancing urinary glucose excretion through Dapagliflozin and stimulating insulin secretion via Gliclazide, providing a synergistic approach for improved metabolic regulation. Its consistent efficacy and safety profile make it a preferred option for doctors treating complex diabetic patients.
For suppliers, Dapoflit G Tablet is a high-demand product in the anti-diabetic segment, offering excellent repeat prescription potential and reliable turnover. Its dual-action benefits make it attractive to endocrinologists, diabetologists, and general practitioners.
Including Dapoflit G in your product portfolio helps distributors strengthen their presence in the growing diabetes care market, enhance brand credibility among healthcare providers, and achieve better business growth with a clinically relevant and trusted formulation.
Possible side effects include hypoglycemia, dizziness, nausea, increased urination, urinary tract infections, and mild gastrointestinal discomfort. Rarely, severe hypoglycemia, dehydration, or allergic reactions may occur.
Dapoflit G Tablet is indicated for the treatment of type 2 diabetes mellitus, especially in patients inadequately controlled on diet, exercise, or monotherapy. It helps reduce blood glucose levels and improve glycemic control.
Use only under medical supervision. Not recommended in patients with type 1 diabetes, severe kidney or liver impairment, or known hypersensitivity to the components. Monitor blood sugar regularly and adjust diet and exercise accordingly.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.
Composition : Dapagliflozin 5mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Sitagliptin Phosphate I.P. 100mg Tablets
Composition : Sitagliptin Phosphate I.P. 50mg + Metformin HCL I.P. 1000mg Tablets
Composition : Sitagliptin Phosphate I.P. 50mg + Metformin HCL I.P. 500mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination has strong demand in the diabetes management segment, making it a high-potential product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes management, especially in patients requiring dual therapy for better glycemic control. It strengthens their antidiabetic portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dapagliflozin 10mg + Gliclazide 60mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, repeat sales, and long-term diabetic patient usage when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this antidiabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.